On Friday, the shares of this company surged 1.58 per cent. The share has a 52-week high and low of Rs 8.66 and 1.58 respectively. The share opened at Rs 3.87 and touched intraday highs and lows of Rs 3.90 and 3.81 respectively. The company has a market cap of Rs 48.2 crore.

The stock gave investors a multibagger return of 250 per cent in 3 years and a whopping 1,260 per cent in 5 years.

The stock gave investors a multibagger return of 225 per cent in just 1 year and a whopping 1,300 per cent in 3 years.

Furthermore, according to the quarterly results, the company reported net sales of Rs 14.08 crore. The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

According to the quarterly results, the company reported net sales of Rs 14.08 crore. The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and the net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

According to the quarterly results, the company reported net sales of Rs 14.08 crore. The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

The company has bagged an order worth Rs 35 crore for manufacturing A.P. (Active pharmaceuticals Ingredient) purification and sterilization Plant with Lyophilizers in small batch API. The company will create an advanced quality control system and R & D facility in new I.P. creation in the field of API & Intermediaries.

The stock has seen heavy buying hitting back-to-back upper circuits and 52-week highs. 

The net sales skyrocketed 3,238 per cent in Q4FY23 over Q4FY22.